Abstract
The USA, the UK and Germany – countries with rather different institutional structures and spending levels – have all put healthcare reforms at the top of their domestic policy agendas. In each case, incentive contracts, intended to deal with shortcomings of the current approach, evoke regulatory concerns. A range of common governance challenges can be identified that market-driven healthcare reforms would need to address.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
